• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

BioHorizons

Anonymous board for BioHorizons
Replies
2
Views
6K
anonymous
Replies
1
Views
3K
anonymous
Replies
1
Views
4K
anonymous
Replies
25
Views
9K
anonymous
Replies
1
Views
5K
anonymous
Replies
4
Views
3K
anonymous
Replies
3
Views
5K
Anonymous
Replies
28
Views
16K
Anonymous
Replies
37
Views
13K
Anonymous
AAP
Replies
14
Views
4K
Anonymous
Replies
51
Views
19K
Anonymous
Replies
11
Views
5K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
37
Views
14K
Anonymous
Replies
22
Views
6K
Anonymous
Replies
3
Views
3K
Anonymous
Replies
6
Views
5K
Anonymous
Replies
85
Views
32K
Anonymous